ZA955443B - Novel mutant hIL-4 proteins as antagonists or partial agonists of human interleukin 4 - Google Patents
Novel mutant hIL-4 proteins as antagonists or partial agonists of human interleukin 4Info
- Publication number
- ZA955443B ZA955443B ZA955443A ZA955443A ZA955443B ZA 955443 B ZA955443 B ZA 955443B ZA 955443 A ZA955443 A ZA 955443A ZA 955443 A ZA955443 A ZA 955443A ZA 955443 B ZA955443 B ZA 955443B
- Authority
- ZA
- South Africa
- Prior art keywords
- proteins
- pct
- antagonists
- human interleukin
- partial agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5406—IL-4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4423131A DE4423131A1 (de) | 1994-07-01 | 1994-07-01 | Neue hIL-4-Mutantenproteine als Antagonisten oder partielle Agonisten des humanen Interleukin 4 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA955443B true ZA955443B (en) | 1996-02-13 |
Family
ID=6522032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA955443A ZA955443B (en) | 1994-07-01 | 1995-06-30 | Novel mutant hIL-4 proteins as antagonists or partial agonists of human interleukin 4 |
Country Status (18)
Country | Link |
---|---|
US (1) | US6130318A (sk) |
EP (1) | EP0769020B1 (sk) |
JP (3) | JPH10502360A (sk) |
KR (1) | KR100393508B1 (sk) |
AT (1) | ATE190068T1 (sk) |
AU (1) | AU705745B2 (sk) |
CA (1) | CA2193993C (sk) |
CZ (1) | CZ292703B6 (sk) |
DE (2) | DE4423131A1 (sk) |
DK (1) | DK0769020T3 (sk) |
ES (1) | ES2145280T3 (sk) |
GR (1) | GR3033498T3 (sk) |
HU (1) | HU221416B1 (sk) |
NO (1) | NO965621L (sk) |
SK (1) | SK284391B6 (sk) |
TW (1) | TW458984B (sk) |
WO (1) | WO1996001274A1 (sk) |
ZA (1) | ZA955443B (sk) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9415379D0 (en) * | 1994-07-29 | 1994-09-21 | Smithkline Beecham Plc | Novel compounds |
AU1872999A (en) | 1997-11-13 | 1999-06-07 | Europaisches Laboratorium Fur Molekularbiologie (Embl) | Design of coiled-coil dimer derived antagonists of 4-helix bundle cytokine spe cific receptors |
CN1896231B (zh) | 1998-08-06 | 2012-09-05 | 山景药品公司 | 分离四聚体尿酸氧化酶的方法 |
IL161121A0 (en) | 2001-10-03 | 2004-08-31 | Harvard College | Copolymers for suppression of autoimmune diseases, and methods of use |
CA2513483C (en) * | 2003-01-17 | 2011-11-29 | Cornell Research Foundation, Inc. | Injectable hydrogel microspheres from aqueous two-phase system |
US7404957B2 (en) * | 2003-08-29 | 2008-07-29 | Aerovance, Inc. | Modified IL-4 mutein receptor antagonists |
US7785580B2 (en) * | 2003-08-29 | 2010-08-31 | Aerovance, Inc. | Modified IL-4 mutein receptor antagonists |
US7635754B2 (en) * | 2004-09-22 | 2009-12-22 | Aerovance, Inc. | Interleukin-9 and interleukin-4 chimeric antagonist muteins and methods of using same |
US20090142294A1 (en) * | 2005-01-25 | 2009-06-04 | Apollo Life Sciences Limited | Parameter selected gm-csf, il-3, il-4, il-5 and chimeras thereof for therapeutic and diagnostic purposes |
BRPI0612942A2 (pt) * | 2005-04-11 | 2012-10-09 | Savient Pharmaceuticals Inc | forma variante de oxidase de urato e uso do mesmo |
LT3321359T (lt) | 2005-04-11 | 2021-05-10 | Horizon Pharma Rheumatology Llc | Urato oksidazės variantinės formos ir jų panaudojimas |
US20070009479A1 (en) * | 2005-06-17 | 2007-01-11 | Aerovance, Inc. | Methods for treating dermatitis using mutant human IL-4 compositions |
JP2009525267A (ja) * | 2006-01-11 | 2009-07-09 | アエロヴァンス インコーポレイティッド | ヒトおよび非ヒト霊長類において喘息を処置するための方法および組成物 |
JP2010514409A (ja) * | 2006-06-21 | 2010-05-06 | アポゲニクス ゲゼルシャフト ミット ベシュレンクテル ハフツング | ヒトの癌における鑑別式サイトカイン発現 |
WO2008003514A2 (en) * | 2006-07-06 | 2008-01-10 | Apogenix Gmbh | Human il-4 muteins in combination with chemotherapeutics or pro-apoptotic agents in cancer therapy |
WO2008101671A2 (en) * | 2007-02-19 | 2008-08-28 | Apogenix Gmbh | Il-4 fc fusion proteins |
CA2693785A1 (en) * | 2007-07-11 | 2009-01-15 | Aerovance, Inc. | Pharmaceutical polypeptide dry powder aerosol formulation and method of preparation |
JP2009217498A (ja) * | 2008-03-10 | 2009-09-24 | Sato Knowledge & Intellectual Property Institute | 印字試験システム |
US8182626B2 (en) | 2008-10-30 | 2012-05-22 | Continental Ag | Tire composition with improved vulcanizing agent |
HUP1200205A3 (en) | 2009-06-25 | 2012-09-28 | Savient Pharmaceuticals | Method and kits for perdicting infusion reaction risk and antibody-mediated low of response by monitoring serum uric acid during pegylated uricare therapy |
US9512194B2 (en) | 2012-01-27 | 2016-12-06 | The Board Of Trustees Of The Leland Stanford Junior University | Modified IL-13 polypeptides |
US9738696B2 (en) * | 2012-08-09 | 2017-08-22 | The Board Of Trustees Of The Leland Stanford Junior University | Superkines and synthekines: repurposed cytokines with new and enhanced signaling activities |
EP2813242A1 (en) * | 2013-06-13 | 2014-12-17 | PLS-Design GmbH | Low molecular weight immune-modulators as adjuvants for specific immunotherapy |
EP3910061A1 (en) | 2013-09-24 | 2021-11-17 | Medicenna Therapeutics, Inc. | Interleukin-4 receptor-binding fusion proteins and uses thereof |
CN112538108B (zh) * | 2020-12-24 | 2022-06-28 | 郑州大学 | 高亲和pvr突变体 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773919A (en) * | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US4263428A (en) * | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
JPS6023084B2 (ja) * | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
DE3169595D1 (en) * | 1980-11-10 | 1985-05-02 | Gersonde Klaus | Method of preparing lipid vesicles by ultrasonic treatment, the use of this method and apparatus for its application |
US4485045A (en) * | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
US4640835A (en) * | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
EP0088046B1 (de) * | 1982-02-17 | 1987-12-09 | Ciba-Geigy Ag | Lipide in wässriger Phase |
DE3218121A1 (de) * | 1982-05-14 | 1983-11-17 | Leskovar, Peter, Dr.-Ing., 8000 München | Arzneimittel zur tumorbehandlung |
EP0102324A3 (de) * | 1982-07-29 | 1984-11-07 | Ciba-Geigy Ag | Lipide und Tenside in wässriger Phase |
US4544545A (en) * | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
HUT35524A (en) * | 1983-08-02 | 1985-07-29 | Hoechst Ag | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance |
DE3336583A1 (de) * | 1983-09-26 | 1985-04-25 | Udo Dr. 8400 Regensburg Ehrenfeld | Erzeugnis zur diagnose und therapie von malignen tumoren |
DE3474511D1 (en) * | 1983-11-01 | 1988-11-17 | Terumo Corp | Pharmaceutical composition containing urokinase |
US4496689A (en) * | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
DE3675588D1 (de) * | 1985-06-19 | 1990-12-20 | Ajinomoto Kk | Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist. |
AU597574B2 (en) * | 1986-03-07 | 1990-06-07 | Massachusetts Institute Of Technology | Method for enhancing glycoprotein stability |
US4791192A (en) * | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
JPH02501827A (ja) * | 1986-12-19 | 1990-06-21 | イミュネックス・コーポレーション | ヒト・インターロイキン‐4 ミューテイン |
AU620537B2 (en) * | 1986-12-19 | 1992-02-20 | Immunex Corporation | Human interleukin-4 muteins |
NZ226414A (en) * | 1987-10-02 | 1992-07-28 | Genentech Inc | Cd4 peptide adhesion variants and their preparation and use |
US5013556A (en) * | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
JPH06506831A (ja) * | 1991-05-02 | 1994-08-04 | ノボザイムス アクティーゼルスカブ | ラムノガラクツロナーゼ、対応するdna配列、ラムノガラクツロナーゼ含有酵素調製物および該酵素調製物の用途 |
DE4137333A1 (de) * | 1991-11-13 | 1993-05-19 | W Prof Dr Sebald | Therapeutische mittel, die antagonisten oder partielle agonisten des humanen interleukin 4 sind oder diese enthalten, hil-4-mutantenproteine sowie vefahren zu deren herstellung |
US5298410A (en) * | 1993-02-25 | 1994-03-29 | Sterling Winthrop Inc. | Lyophilized formulation of polyethylene oxide modified proteins with increased shelf-life |
-
1994
- 1994-07-01 DE DE4423131A patent/DE4423131A1/de not_active Withdrawn
-
1995
- 1995-06-19 SK SK1692-96A patent/SK284391B6/sk not_active IP Right Cessation
- 1995-06-19 KR KR1019960707590A patent/KR100393508B1/ko not_active IP Right Cessation
- 1995-06-19 EP EP95924273A patent/EP0769020B1/de not_active Expired - Lifetime
- 1995-06-19 DE DE59507920T patent/DE59507920D1/de not_active Expired - Lifetime
- 1995-06-19 CA CA002193993A patent/CA2193993C/en not_active Expired - Fee Related
- 1995-06-19 ES ES95924273T patent/ES2145280T3/es not_active Expired - Lifetime
- 1995-06-19 AU AU28852/95A patent/AU705745B2/en not_active Ceased
- 1995-06-19 HU HU9603563A patent/HU221416B1/hu not_active IP Right Cessation
- 1995-06-19 US US08/765,012 patent/US6130318A/en not_active Expired - Lifetime
- 1995-06-19 AT AT95924273T patent/ATE190068T1/de active
- 1995-06-19 DK DK95924273T patent/DK0769020T3/da active
- 1995-06-19 JP JP8503644A patent/JPH10502360A/ja active Pending
- 1995-06-19 CZ CZ19963848A patent/CZ292703B6/cs not_active IP Right Cessation
- 1995-06-19 WO PCT/EP1995/002358 patent/WO1996001274A1/de active IP Right Grant
- 1995-06-30 ZA ZA955443A patent/ZA955443B/xx unknown
- 1995-07-10 TW TW084107101A patent/TW458984B/zh not_active IP Right Cessation
-
1996
- 1996-12-30 NO NO965621A patent/NO965621L/no not_active Application Discontinuation
-
2000
- 2000-05-24 GR GR20000401195T patent/GR3033498T3/el unknown
-
2006
- 2006-11-15 JP JP2006309383A patent/JP2007051161A/ja active Pending
-
2010
- 2010-12-06 JP JP2010271687A patent/JP2011102302A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2193993C (en) | 2008-11-18 |
NO965621D0 (no) | 1996-12-30 |
AU705745B2 (en) | 1999-06-03 |
HUT77577A (hu) | 1998-06-29 |
AU2885295A (en) | 1996-01-25 |
ES2145280T3 (es) | 2000-07-01 |
JP2007051161A (ja) | 2007-03-01 |
HU9603563D0 (en) | 1997-02-28 |
SK169296A3 (en) | 1997-08-06 |
CZ292703B6 (cs) | 2003-11-12 |
DE4423131A1 (de) | 1996-01-04 |
GR3033498T3 (en) | 2000-09-29 |
DE59507920D1 (de) | 2000-04-06 |
TW458984B (en) | 2001-10-11 |
WO1996001274A1 (de) | 1996-01-18 |
CZ384896A3 (en) | 1997-06-11 |
NO965621L (no) | 1996-12-30 |
HU221416B1 (en) | 2002-09-28 |
EP0769020A1 (de) | 1997-04-23 |
SK284391B6 (sk) | 2005-03-04 |
JPH10502360A (ja) | 1998-03-03 |
DK0769020T3 (da) | 2000-07-31 |
EP0769020B1 (de) | 2000-03-01 |
JP2011102302A (ja) | 2011-05-26 |
KR100393508B1 (ko) | 2003-10-23 |
US6130318A (en) | 2000-10-10 |
ATE190068T1 (de) | 2000-03-15 |
CA2193993A1 (en) | 1996-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA955443B (en) | Novel mutant hIL-4 proteins as antagonists or partial agonists of human interleukin 4 | |
ATE179330T1 (de) | Verbesserte alpha-interferon-zusammensetzung und verfahren zu ihrer herstellung aus leukocyten des menschlichen peripheren blute | |
MX9702932A (es) | L-ribofuranosilnucleosidos. | |
HU9401369D0 (en) | Human il-4 mutant proteins, thats containing pharmaceutical product and process for producing of proteins | |
MX9602259A (es) | Proteina modificada quimicamente en el nitrogeno terminal, composiciones que las incluyen y metodos para su preparacion. | |
GB9411356D0 (en) | Yeast strains | |
MX9602750A (es) | Proteinas de la region v receptoras de antigenos de la celula t y metodos para la preparacion de las mismas. | |
EP0609280A4 (en) | Human il-3 variants. | |
FI972703A0 (fi) | Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia | |
DE59610632D1 (de) | Varianten des humanen rekombinanten interferon-gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität | |
PL324424A1 (en) | Therapeutic factors and autoimmunological diseases | |
MX9702926A (es) | L-eritrosilnucleosidos. | |
AU2824289A (en) | Thienotricyclene for the treatment of bronchial diseases | |
MX9702927A (es) | L-piranosilnucleosidos. | |
MY103584A (en) | 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it | |
GB9723630D0 (en) | M.vaccae preparation and its use | |
EP1878794A3 (en) | Compositions and methods for the treatment of immune related diseases | |
MX9800686A (es) | Nueva proteina hmw humana mp52s. |